PL2490671T3 - Liposomy hydrolizowane przez sPLA2 o ulepszonej trwałości w przechowywaniu - Google Patents

Liposomy hydrolizowane przez sPLA2 o ulepszonej trwałości w przechowywaniu

Info

Publication number
PL2490671T3
PL2490671T3 PL10772956T PL10772956T PL2490671T3 PL 2490671 T3 PL2490671 T3 PL 2490671T3 PL 10772956 T PL10772956 T PL 10772956T PL 10772956 T PL10772956 T PL 10772956T PL 2490671 T3 PL2490671 T3 PL 2490671T3
Authority
PL
Poland
Prior art keywords
storag
stability
improved
spla2 hydrolysable
hydrolysable liposomes
Prior art date
Application number
PL10772956T
Other languages
English (en)
Polish (pl)
Inventor
Mogens Winkel Madsen
Sune Allan Petersen
Anders Falk Vikbjerg
Original Assignee
Bio Bedst Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Bedst Aps filed Critical Bio Bedst Aps
Publication of PL2490671T3 publication Critical patent/PL2490671T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL10772956T 2009-10-23 2010-10-25 Liposomy hydrolizowane przez sPLA2 o ulepszonej trwałości w przechowywaniu PL2490671T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200901150A DK177529B1 (en) 2009-10-23 2009-10-23 Liposomes with improved storage stability
PCT/DK2010/050283 WO2011047689A2 (en) 2009-10-23 2010-10-25 Liposomes with improved storage stability
EP10772956.8A EP2490671B1 (en) 2009-10-23 2010-10-25 Spla2 hydrolysable liposomes with improved storag stability

Publications (1)

Publication Number Publication Date
PL2490671T3 true PL2490671T3 (pl) 2014-08-29

Family

ID=43533079

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10772956T PL2490671T3 (pl) 2009-10-23 2010-10-25 Liposomy hydrolizowane przez sPLA2 o ulepszonej trwałości w przechowywaniu

Country Status (16)

Country Link
US (1) US9820941B2 (enExample)
EP (1) EP2490671B1 (enExample)
JP (1) JP5778160B2 (enExample)
CN (1) CN102639114B (enExample)
AU (1) AU2010310240B2 (enExample)
CA (1) CA2772973C (enExample)
CY (1) CY1115139T1 (enExample)
DK (2) DK177529B1 (enExample)
ES (1) ES2465565T3 (enExample)
HR (1) HRP20140413T1 (enExample)
PL (1) PL2490671T3 (enExample)
PT (1) PT2490671E (enExample)
RS (1) RS53321B (enExample)
SI (1) SI2490671T1 (enExample)
SM (1) SMT201400065B (enExample)
WO (1) WO2011047689A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2123258A1 (en) 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomes for drug delivery
DK177532B1 (en) 2009-09-17 2013-09-08 Bio Bedst Aps Medical use of sPLA2 hydrolysable liposomes
EP2394640A1 (en) * 2010-05-21 2011-12-14 MediGene AG Improved liposomal formulations of lipophilic compounds
WO2015166987A1 (ja) * 2014-04-30 2015-11-05 富士フイルム株式会社 リポソーム組成物及びその製造方法
LT3138555T (lt) 2014-04-30 2021-03-25 Fujifilm Corporation Liposomų kompozicija ir jų gamybos būdas
EP3138557B1 (en) 2014-04-30 2023-06-07 FUJIFILM Corporation Liposome composition and method for producing same
PT3291797T (pt) 2015-05-04 2020-10-19 Versantis AG Método para preparar vesículas de gradiente de ph transmembranar
US9725769B1 (en) 2016-10-07 2017-08-08 Oncology Venture ApS Methods for predicting drug responsiveness in cancer patients
AU2017258901A1 (en) 2016-12-30 2018-07-19 Allarity Therapeutics Europe ApS Methods for predicting drug responsiveness in cancer patients
AU2019200325A1 (en) * 2018-01-31 2019-08-15 Liplasome Pharma Aps Methods for treating cancer and predicting drug responsiveness in cancer patients
CN110496103B (zh) * 2018-05-18 2022-05-10 上海维洱生物医药科技有限公司 一种多西他赛棕榈酸酯脂质体及其制备方法
WO2019244978A1 (ja) 2018-06-20 2019-12-26 富士フイルム株式会社 ゲムシタビンを内包するリポソーム組成物および免疫チェックポイント阻害剤を含む組合せ医薬

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
CA1335348C (en) 1988-03-04 1995-04-25 Yasuaki Ogawa Liposome composition
JP2931981B2 (ja) * 1988-03-04 1999-08-09 武田薬品工業株式会社 リポソーム製剤およびその製造法
FI895340A7 (fi) * 1988-11-14 1990-05-15 Bristol Myers Squibb Co Hypertoninen cisplatin-liuos
JPH05194192A (ja) * 1991-08-21 1993-08-03 Shionogi & Co Ltd 分散性の改善された温度感受性ｍｌｖ型リポソ−ム
JPH069374A (ja) * 1992-04-07 1994-01-18 Banyu Pharmaceut Co Ltd リポソ−ム製剤およびその製造法
US6027726A (en) 1994-09-30 2000-02-22 Inex Phamaceuticals Corp. Glycosylated protein-liposome conjugates and methods for their preparation
US5858397A (en) 1995-10-11 1999-01-12 University Of British Columbia Liposomal formulations of mitoxantrone
JP2001501173A (ja) * 1996-08-23 2001-01-30 アルザ コーポレイション シスプラチン化合物を含有するリポソーム
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
WO2001058910A2 (en) * 2000-02-10 2001-08-16 Liplasome Pharma A/S Lipid-based drug delivery systems
JP2003530339A (ja) 2000-04-12 2003-10-14 リプラサム ファーマ アー／エス 寄生虫感染症の医療用途のための、ホスホリパーゼａ２分解性脂質誘導体を含有する脂質ベースの薬物送達システム
US20030026831A1 (en) 2001-04-20 2003-02-06 Aparna Lakkaraju Anionic liposomes for delivery of bioactive agents
CA2383259A1 (en) 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
PT1443900E (pt) 2001-11-13 2012-08-01 Celator Pharmaceuticals Inc Composições de veículo lipídico com estabilidade melhorada no sangue
US20040022842A1 (en) 2002-06-03 2004-02-05 Mebiopharm Co., Ltd. Liposome preparations containing oxaliplatin
EP1643971A2 (en) 2003-05-22 2006-04-12 Neopharm, Inc. Liposomal formulations comprising a combination of two or more active agents
GB0312309D0 (en) * 2003-05-29 2003-07-02 Gaslini Children S Hospital G Targeted liposome
WO2006025411A1 (ja) 2004-08-31 2006-03-09 Astellas Pharm. Inc. 細胞内薬物送達改善リポソーム
WO2006048017A1 (en) 2004-11-03 2006-05-11 Liplasome Pharma A/S Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof
WO2007005754A2 (en) * 2005-07-01 2007-01-11 Alza Corporation Liposomal delivery vehicle for hydrophobic drugs
CN101040853B (zh) * 2006-03-22 2010-05-12 上海医药工业研究院 一种草乌甲素多泡脂质体及其制备方法
EP2004236A2 (en) 2006-03-23 2008-12-24 Liplasome Pharma A/S Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis
BRPI0714386A2 (pt) 2006-07-14 2012-12-25 Fmc Biopolymer As hidrogel, conta, mÉtodos para produzir um hidrogel ou uma conta, para implantar uma conta ou dispositivo mÉdico implantÁvel e cÉlulas em um paciente, para bloquear vasos sanguÍneos, e para formar um hidrogel, dispositivo mÉdico implantÁvel, formulaÇço de liberaÇço de droga, agente de contraste ou material radioopaco, e, composiÇço terapÊutica embàlica
CN100563646C (zh) 2007-07-13 2009-12-02 陈祥峰 一种奥沙利铂脂质体葡萄糖制剂的制备方法
EP2123258A1 (en) * 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomes for drug delivery

Also Published As

Publication number Publication date
AU2010310240A1 (en) 2012-03-22
CA2772973A1 (en) 2011-04-28
AU2010310240B2 (en) 2015-11-26
US9820941B2 (en) 2017-11-21
CN102639114A (zh) 2012-08-15
ES2465565T3 (es) 2014-06-06
EP2490671B1 (en) 2014-03-05
CN102639114B (zh) 2015-04-01
CA2772973C (en) 2017-08-15
SI2490671T1 (sl) 2014-07-31
SMT201400065B (it) 2014-07-07
CY1115139T1 (el) 2016-12-14
PT2490671E (pt) 2014-05-30
RS53321B (sr) 2014-10-31
US20120219618A1 (en) 2012-08-30
DK200901150A (en) 2011-04-24
JP5778160B2 (ja) 2015-09-16
HRP20140413T1 (hr) 2014-07-04
WO2011047689A2 (en) 2011-04-28
DK2490671T3 (da) 2014-06-16
JP2013508315A (ja) 2013-03-07
WO2011047689A3 (en) 2011-11-17
DK177529B1 (en) 2013-09-08
EP2490671A2 (en) 2012-08-29

Similar Documents

Publication Publication Date Title
SI2490671T1 (sl) Liposomi, ki jih je mogoče hidrolizirati sPLA2 in imajo izboljšano stabilnost pri shranjevanju
SG11201602868WA (en) Probiotic stabilization
PL2507235T3 (pl) Triazolopirymidyny
EP2619711A4 (en) Machine-readable symbols
AU331433S (en) Canister
AP2013006994A0 (en) Illuninated pole
EP2380047A4 (en) IMPROVED PHOTOCATHODE AT CUBE HEIGHTS
GB0918375D0 (en) Construct
GB201421222D0 (en) Hollow pot
PL2261113T3 (pl) Śruba
GB201014760D0 (en) Multi section pole
PT2516029E (pt) Cobertura para a cabeça transformável
TWM372743U (en) Improved structure of Kendama
GB0905193D0 (en) Pole Support
TWM365675U (en) Improved structure of teapoy
GB0903635D0 (en) Solid liposomes
PH32009000282S1 (en) Statue
GB2486269B (en) Improved swimming float
GB0908902D0 (en) Easy walls
GB0921043D0 (en) Improvements to high walled enclosed stadia
PL391907A1 (pl) Przekładka stabilizacyjna
PL119227U1 (pl) Palnik segmentowy
GB201013352D0 (en) Lacey
GB201007483D0 (en) Homewash comforter
GB201021785D0 (en) Interlocking concealed mountings